NO20083239L - Anvendelse av adenosin A2A reseptor agonist for fremstilling av et topisk medikament for å akselerere helingen av et sår - Google Patents
Anvendelse av adenosin A2A reseptor agonist for fremstilling av et topisk medikament for å akselerere helingen av et sårInfo
- Publication number
- NO20083239L NO20083239L NO20083239A NO20083239A NO20083239L NO 20083239 L NO20083239 L NO 20083239L NO 20083239 A NO20083239 A NO 20083239A NO 20083239 A NO20083239 A NO 20083239A NO 20083239 L NO20083239 L NO 20083239L
- Authority
- NO
- Norway
- Prior art keywords
- adenosine
- healing
- accelerating
- wound
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33516901P | 2001-10-25 | 2001-10-25 | |
| US37572302P | 2002-04-26 | 2002-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20083239L true NO20083239L (no) | 2004-06-23 |
Family
ID=26989581
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042126A NO326625B1 (no) | 2001-10-25 | 2004-05-24 | Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner |
| NO20083239A NO20083239L (no) | 2001-10-25 | 2008-07-22 | Anvendelse av adenosin A2A reseptor agonist for fremstilling av et topisk medikament for å akselerere helingen av et sår |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042126A NO326625B1 (no) | 2001-10-25 | 2004-05-24 | Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6951932B2 (no) |
| EP (1) | EP1446413A4 (no) |
| JP (1) | JP2005511551A (no) |
| KR (1) | KR20040049001A (no) |
| CN (1) | CN1608076A (no) |
| AU (1) | AU2002336668B2 (no) |
| BR (1) | BR0213557A (no) |
| CA (1) | CA2465264C (no) |
| IL (2) | IL161608A0 (no) |
| NO (2) | NO326625B1 (no) |
| NZ (1) | NZ532541A (no) |
| PL (1) | PL369327A1 (no) |
| WO (1) | WO2003035662A1 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7342003B2 (en) * | 2001-10-25 | 2008-03-11 | King Pharmaceuticals Research And Development, Inc. | Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs |
| US20070232561A1 (en) * | 2006-03-31 | 2007-10-04 | Edward Leung | Pharmaceutical compositions for promoting wound healing |
| EP2198887A4 (en) | 2007-10-19 | 2011-11-30 | Univ Tokyo | THERAPEUTIC AGENT FOR LEUCODERM AND METHOD FOR ACCELERATING PIGMENTATION |
| WO2009085909A1 (en) * | 2007-12-20 | 2009-07-09 | King Pharmaceuticals Research And Development, Inc. | Crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE792155A (fr) * | 1971-12-01 | 1973-05-30 | Takeda Chemical Industries Ltd | Nouveaux derives de l'adenosine et leur procede de production |
| JPS4911896A (no) | 1972-05-15 | 1974-02-01 | ||
| JPS4920198A (no) | 1972-06-26 | 1974-02-22 | ||
| JPS49124096A (no) | 1973-03-31 | 1974-11-27 | ||
| JPS5053393A (no) | 1973-09-18 | 1975-05-12 | ||
| US5140015A (en) * | 1990-02-20 | 1992-08-18 | Whitby Research, Inc. | 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
| WO1994023723A1 (en) * | 1993-04-15 | 1994-10-27 | New York University | Adenosine receptor agonists for the promotion of wound healing |
-
2002
- 2002-10-24 US US10/281,291 patent/US6951932B2/en not_active Expired - Fee Related
- 2002-10-24 BR BR0213557-4A patent/BR0213557A/pt not_active Withdrawn
- 2002-10-24 CN CNA028261437A patent/CN1608076A/zh active Pending
- 2002-10-24 NZ NZ532541A patent/NZ532541A/en not_active IP Right Cessation
- 2002-10-24 AU AU2002336668A patent/AU2002336668B2/en not_active Ceased
- 2002-10-24 IL IL16160802A patent/IL161608A0/xx unknown
- 2002-10-24 CA CA2465264A patent/CA2465264C/en not_active Expired - Fee Related
- 2002-10-24 PL PL02369327A patent/PL369327A1/xx not_active Application Discontinuation
- 2002-10-24 KR KR10-2004-7006198A patent/KR20040049001A/ko active Search and Examination
- 2002-10-24 EP EP02773916A patent/EP1446413A4/en not_active Withdrawn
- 2002-10-24 WO PCT/US2002/034313 patent/WO2003035662A1/en active IP Right Grant
- 2002-10-24 JP JP2003538175A patent/JP2005511551A/ja active Pending
-
2004
- 2004-04-25 IL IL161608A patent/IL161608A/en not_active IP Right Cessation
- 2004-05-24 NO NO20042126A patent/NO326625B1/no not_active IP Right Cessation
-
2008
- 2008-07-22 NO NO20083239A patent/NO20083239L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1446413A1 (en) | 2004-08-18 |
| JP2005511551A (ja) | 2005-04-28 |
| NO20042126L (no) | 2004-06-23 |
| EP1446413A4 (en) | 2007-10-17 |
| WO2003035662A1 (en) | 2003-05-01 |
| AU2002336668B2 (en) | 2008-01-10 |
| US20030199686A1 (en) | 2003-10-23 |
| IL161608A (en) | 2010-05-31 |
| NO326625B1 (no) | 2009-01-19 |
| NZ532541A (en) | 2005-09-30 |
| CA2465264C (en) | 2010-09-07 |
| AU2002336668B8 (en) | 2003-05-06 |
| KR20040049001A (ko) | 2004-06-10 |
| US6951932B2 (en) | 2005-10-04 |
| PL369327A1 (en) | 2005-04-18 |
| BR0213557A (pt) | 2004-10-26 |
| CN1608076A (zh) | 2005-04-20 |
| CA2465264A1 (en) | 2003-05-01 |
| IL161608A0 (en) | 2004-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2016031I2 (el) | Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων | |
| EE200300586A (et) | Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks | |
| DE50012448D1 (de) | Retardierte, orale, pharmazeutische darreichnungsformen mit tramadol | |
| EE200200656A (et) | Ravis kasutatavad tropaani derivaadid | |
| ATE293627T1 (de) | Adenosin a2a rezeptor antagonisten | |
| PT1189916E (pt) | N-pirazole agonistas do receptor a2a | |
| NO20023765L (no) | Anvendelse av sentrale cannabinoidreseptor-antagonister for fremstilling av medisiner som er anvendbare for å fremme stans avtobakksbruk | |
| DE60115418D1 (de) | Mikroinfusionsvorrichtung zur verabreichung von medikamenten | |
| NO20022970D0 (no) | Hydrogel-drevet medikamentdoseringsform | |
| ATE453647T1 (de) | Adenosin a2a rezeptor antagonisten | |
| NO20030627D0 (no) | Hydrogel-drevet medikament doseringsform | |
| ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
| NO20040145L (no) | Anvendelse av benzensulfonamidderivater for fremstilling av et medikament | |
| HUP0700039A2 (en) | Use of cannabinoid drugs for the preparation of medicines for decreasing cell proliferation | |
| ATE317844T1 (de) | Adenosine a2a receptor antagonisten | |
| ATE358130T1 (de) | Bicyclische (1,2,4ö-triazol adenosin a2a rezeptor antagonisten | |
| NO20083239L (no) | Anvendelse av adenosin A2A reseptor agonist for fremstilling av et topisk medikament for å akselerere helingen av et sår | |
| PT1077703E (pt) | Formas de medicamentos orais com libertacao reproduzivel da substancia activa gatifloxacina ou de seus sais ou hidratos farmaceuticamente aceitaveis | |
| DE50308945D1 (de) | Mehrschichtiges transmucosales therapeutisches system | |
| FI20000780A (fi) | Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi | |
| NO20025394D0 (no) | Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer | |
| DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| NO20020555D0 (no) | Mikropartikler for lungeadministrering | |
| DE60005507D1 (de) | Oral aktive a1 adenosin rezeptor agonisten | |
| DE60331041D1 (de) | Orale dosierform für die kontrollierte arzneimittelfreisetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |